VirnetX Holding Corporation — Q2 2017 Form 10-Q
Reporting period: Quarter and six months ended June 30, 2017. Unaudited financial statements; amounts below are in USD thousands except per-share data.
Business context
VirnetX seeks to commercialize its communications-security patent portfolio through licenses and royalties, while developing and marketing its Gabriel secure communications products. Revenue remains limited and is largely recognized over time from a previously collected settlement contract. The company reported more than 80 small and medium businesses had installed Gabriel products.
Financial results and liquidity
| Metric | Q2 2017 | Q2 2016 | Six months 2017 | Six months 2016 |
|---|---|---|---|---|
| Revenue | $396 | $398 | $771 | $773 |
| Operating expenses | $4,207 | $5,751 | $8,488 | $14,745 |
| Operating loss | $(3,811) | $(5,353) | $(7,717) | $(13,972) |
| Net loss | $(3,798) | $(5,337) | $(7,691) | $(13,948) |
| Loss per share, basic and diluted | $(0.07) | $(0.10) | $(0.13) | $(0.25) |
- Operating-loss margin was approximately negative 962% for Q2 and negative 1,001% for the first half, calculated as operating loss divided by revenue.
- First-half operating cash flow was $(9,390), compared with $(14,164) in 2016. Cash and cash equivalents declined to $2,212 from $6,627 at year-end; available-for-sale investments declined to $4,240 from $9,249.
- At June 30, cash plus investments totaled $6,452; working capital was $4,716, down from $11,240 at December 31, 2016. The filing reports no debt balance.
- Total assets were $9,445 and total liabilities were $4,279. Deferred revenue totaled $3,250, including $1,500 current and $1,750 non-current.
Changes versus comparable periods
Revenue was nearly unchanged year over year. Net loss narrowed by $1,539 in Q2 and $6,257 for the first half, primarily because patent-litigation legal fees fell. First-half SG&A declined $6,318 to $7,496, including a $5,779 reduction in legal fees; research and development expense increased modestly. The share count increased year over year, and 132,511 shares were issued upon vesting of restricted stock units during the first half.
Outlook, risks, contingencies, and unusual items
- Management said available cash and investments, together with potential proceeds from equity offerings, should fund current SG&A, legal costs, and working capital for the foreseeable future. It expects losses from operations and said legal fees could remain at or rise above recent levels over the next two quarters. No quantitative earnings or revenue guidance was provided.
- A proposed private placement with Public Intelligence Technology Associates for approximately $20 million, in exchange for 5,494,505 shares at $3.64 per share, had not closed. The investor’s financing sources were still conducting diligence; VirnetX said it could not assure completion or recovery of the amount due. The agreements also contemplate revenue-sharing arrangements related to Japanese business.
- VirnetX disclosed nine pending intellectual-property matters. In Apple I, a September 2016 jury awarded $302.4 million; post-trial motions and final judgment remained pending. A separate Apple II retrial had no scheduled date. These matters are uncertain, and the filing does not report the verdict amounts as recognized revenue.
- The company’s key business risks include dependence on patent licensing and litigation, patent challenges and invalidation proceedings, limited product revenue, potential need for additional capital and dilution, and volatile operating results. Management maintained a full valuation allowance against deferred tax assets, citing losses and uncertainty about future taxable income.
- Management concluded disclosure controls and procedures were effective as of June 30, 2017. No material changes in internal control over financial reporting were reported.
Important facts for investors to verify
- Whether the proposed $20 million private placement closed, and the resulting dilution and revenue-sharing obligations.
- Updated cash burn, legal spending, and available liquidity relative to management’s “foreseeable future” assessment.
- Final rulings and appeal status for the Apple cases, including whether any verdict becomes enforceable or collectible.
- Evidence of recurring licensing, royalty, or product revenue beyond amortization of the previously collected settlement.
- Patent validity and licensing developments, including the outcomes of pending review proceedings and their effect on the portfolio.